Page 21 - Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu

Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu

8. UptoDate. Erişim adresi: https://www.uptodate.com/contents/spirami- 25. Katlama C, De Wit S, O’Doherty E, Van Glabeke M, Clumeck N. Pyrimeth-
sin-united-states-available-via-fda-or-other-investigational-drug-ind-pro- amine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-
tocol-only-drug-information. (Erişim tarihi: 09.05.2022). term therapy for toxoplasmic encephalitis in patients with AIDS. Clin
9. Deck DH, Winston LG. Sulfonamides, Trimethoprim & Quinolones. Ed: Infect Dis 1996;22: pp. 268-275. https://doi.org/10.1093/clinids/22.2.268
th
Katzung BG. Basic and Clinical Pharmacology. 12 edition. The McGraw- 26. Dannemann B, McCutchan JA, Israelski D, Antoniskis D, Leport C, Luft B,
Hill Companies. New York 2012;46, pp. 831-838 et al. Treatment of toxoplasmic encephalitis in patients with AIDS: A ran-
10. Zinner SH, Mayer KH. Sulfonamides and Trimethoprim; Trimethop- domized trial comparing pyrimethamine plus clindamycin to pyrimeth-
rim-Sulfamethoxazole. Mandell, Douglas, and Bennett’s Principles and amine plus sulfadiazine. Ann Intern Med 1992;116(1):33-43. https://doi.
Practice of Infectious Diseases. Editors: John E. Bennett JE, Dolin R, Blaser org/10.7326/0003-4819-116-1-33
MJ. Ninth Edition. Elsevier, Philadelphia. 2020; 34, pp. 416-425. 27. Feliciano-Alfonso JE, Muñoz-Ortiz J, Marín-Noriega MA, Vargas-Vil-
11. Choquet-Kastylevsky G, Vial T, Descotes J. Allergic adverse reactions to lanueva A, Triviño-Blanco L, Carvajal-Saiz N, et al. Safety and efficacy of
sulfonamides. Curr Allergy Asthma Rep 2002;2(1):16-25. https://doi. different antibiotic regimens in patients with ocular toxoplasmosis: Sys-
org/10.1007/s11882-002-0033-y tematic review and meta-analysis. Syst Rev 2021;10(1):206. https://doi.
org/10.1186/s13643-021-01758-7
12. Kaye A. J toxoplasmosis: Diagnosis, treatment, and prevention in con-
genitally exposed infants. Pediatr Health Care 2011;25(6):355-64. 28. Duffy CR, Huang Y, Andrikopoulou M, Stern-Ascher CN, Wright JD,
https://doi.org/10.1016/j.pedhc.2010.04.008 Goffman D, et al. Clindamycin, gentamicin, and risk for Clostridium
difficile infection and acute kidney ınjury during delivery hospitali-
13. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363(9425):1965- zations. Obstet Gynecol. 2020;135(1):59-67. https://doi.org/10.1097/
76. https://doi.org/10.1016/S0140-6736(04)16412-X
AOG.0000000000003568
14. Ben-Harari RR, Goodwin E, Casoy J. Adverse event profile of pyrimeth- 29. Aygun C, Kocaman O, Gurbuz Y, Senturk O, Hulagu S. Clindamy-
amine-based therapy in toxoplasmosis: A systematic review. Drugs R D cin-induced acute cholestatic hepatitis. World J Gastroenterol
2017;17(4):523-44. https://doi.org/10.1007/s40268-017-0206-8
2007;13(40):5408-10. https://doi.org/10.3748/wjg.v13.i40.5408
15. Chirgwin K, Hafner R, Leport C, Remington J, Andersen J, Bosler EM, et al. 30. Yang Y, Chen S, Yang F, Zhang L, Alterovitz G, Zhu H, et al. HLA-B*51:01
Randomized phase II trialof atovaquone with pyrimethamine or sulfadi- is strongly associated with clindamycin-related cutaneous adverse
azine for treatmentof toxoplasmic encephalitis in patients with acquired drug reactions. Pharmacogenomics J 2017;17(6):501-5. https://doi.
immunod-eficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical- org/10.1038/tpj.2016.61
Trials Group 237/Agence Nationale de Recherche sur le SIDA,Essai 039.
Clin Infect Dis 2002;2002:1243-50. https://doi.org/10.1086/339551 31. Nesbitt WJ, Aronof DM. Macrolides and Clindamycin. Mandell, Douglas,
and Bennett’s Principles and Practice of Infectious Diseases. Editors: John
16. UptoDate. Erişim adresi: https://www.uptodate.com/contents/py- E. Bennett JE, Dolin R, Blaser MJ. Ninth Edition. Elsevier, Philadelphia.
rimethamine-drug-information?search= pyrimethamine (Erişim tarihi: 2020; 34, pp. 359-374.
04.06.2022).
32. UptoDate. Erişim adresi: https://www.uptodate.com/contents/clinda-
17. Hernandez AV, Thota P, Pellegrino D, Pasupuleti V, Benites-Zapata VA, mycin-systemic-drug-information?search= clindamycin- (Erişim tarihi:
Deshpande A, et. al. A systematic review and meta-analysis of the rel- 04.05.2022).
ative efficacy and safety of treatment regimens for HIV-associated cere-
bral toxoplasmosis: Is trimethoprim-sulfamethoxazole a real option? HIV 33. Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Shahdin S, Daryani A. Activ-
Med 2017;18(2):115-24. https://doi.org/10.1111/hiv.12402 ities of anti-toxoplasma drugs and compounds against tissue cysts in
the last three decades (1987 to 2017), a systematic review. Parasitol Res
18. Torre D, Casari S, Speranza F, Donisi A, Gregis G, Poggio A, et al. Ran- 2018;117(10):3045-57. https://doi.org/10.1007/s00436-018-6027-z
domized trial of trimethoprim-sulfamethoxazole versus pyrimeth-
amine-sulfadiazine for therapy of toxoplasmic encephalitis in patients 34. Chirgwin K, Hafner R, Leport C, Remington J, Andersen J, Bosler EM, et al.
with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chem- Randomized phase II trial of atovaquone with pyrimethamine or sulfadi-
other 1998;42(6):1346-9. https://doi.org/10.1128/AAC.42.6.1346 azine for treatment of toxoplasmic encephalitis in patients with acquired
immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical
19. Ho JM-W, Juurlink DN. Considerations when prescribing trinetoprim-sul- Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
famethoxazole. CMAJ 2011;183:1851-7. https://doi.org/10.1503/ Clin Infect Dis 2002;34(9):1243-50. https://doi.org/10.1086/339551
cmaj.111152
35. Panel on Opportunistic Infections in Adults and Adolescents with HIV.
20. Chastain DB, Hutzley VJ, Parekh J, Alegro JVG. Antimicrobial desensitiza- Guidelines for the prevention and treatment of opportunistic infections
tion: A review of published protocols. Pharmacy (Basel). 2019;7(3):112. in adults and adolescents with HIV: recommendations from the Centers
https://doi.org/10.3390/pharmacy7030112
for Disease Control and Prevention, the National Institutes of Health,
21. Antia C, Persad L, Alikhan A. Trimethoprim-sulfamethoxazole-induced and the HIV Medicine Association of the Infectious Diseases Society of
drug eruption with eosinophilia and systemic symptoms (DRESS). J America. Erişim adresi: https://clinicalinfo.hiv.gov/sites/default/files/
Drugs Dermatol 2017;16(10):1043-6. guidelines/documents/Adult_OI.pdf (Erişim tarihi: 6.12.2021).
22. Don BR. The effect of trimethoprim on potassium and uric acid metabo- 36. Romand S, Pudney M, Derouin F. In vitro and in vivo activities of the hy-
lism in normal human subjects. Clin Nephrol 2001;55(1):45-52. droxynaphthoquinone atovaquone alone or combined with pyrimeth-
23. Ho JM-W, Juurlink DN. Considerations when prescribing trinetoprim-sul- amine, sulfadiazine, clarithromycin, or minocycline against Toxoplas-
famethoxazole. CMAJ 2011;183:1851-7. https://doi.org/10.1503/ ma gondii. Antimicrob Agents Chemother 1993;37:2371-8. https://doi.
cmaj.111152 org/10.1128/AAC.37.11.2371
24. Deck DH, Winston LG. Tetracyclines, Macrolides, Clindamycin, Chloram- 37. McCarty JS, Price RN. Antimalarial drugs. Mandell, Douglas, and Ben-
phenicol, Streptogramins, & Oxazolidinones. Ed: Katzung BG. Basic and nett’s Principles and Practice of Infectious Diseases. Editors: John E. Ben-
Clinical Pharmacology. 12th edition. The McGraw-Hill Companies. New nett JE, Dolin R, Blaser MJ. Ninth Edition. Elsevier, Philadelphia. 2020; 34,
York. 2012; 44, pp. 809-819 pp. 519-533.

12